Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Expect further market correction in tariff-driven era: PitchBook
Biotechs will need to be strategic to achieve “tariff-era success” as the sector enters an “America-first resurgence,” according to PitchBook.
Gabrielle Masson
Apr 18, 2025 7:51am
Fierce Biotech Fundraising Tracker: Glycomine, Attovia & more
Apr 16, 2025 10:00am
Glycomine's $115M series C to fund genetic disorder ph. 2 plans
Apr 16, 2025 9:20am
Market volatility adds to 'already challenging' year for IPOs
Apr 11, 2025 9:25am
Third Rock-backed Merida unveils with $121M for autoimmune plans
Apr 8, 2025 11:03am
Cell therapy biotech bags $102M to fund phase 3 epilepsy plans
Apr 3, 2025 1:22pm
